Typicality: | 0.364 |
Saliency: | 0.268 |
in 1994 | 2 | temporal |
in europe | 2 | location |
stent → be approved by → the fda | 4 |
stent → be approved for → use | 4 |
stent → be → approved | 3 |
negative | neutral | positive |
0.086 | 0.766 | 0.148 |
Raw frequency | 11 |
Normalized frequency | 0.268 |
Modifier score | 0.500 |
Perplexity | 40.870 |